# Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation

> **NCT05627505** · — · UNKNOWN · sponsor: **Qingyuan Zhan** · enrollment: 80 (estimated)

## Conditions studied

- Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** metagenomic next-generation sequencing

## Key facts

- **NCT ID:** NCT05627505
- **Lead sponsor:** Qingyuan Zhan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-20
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05627505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05627505, "Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05627505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*